Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :3537
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


This article has been cited by
1Comparative efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukaemia: A systematic review and network meta-analysis
Mariana M. Fachi,Fernanda S. Tonin,Leticia P. Leonart,Karina S. Aguiar,Luana Lenzi,Bonald C. Figueiredo,Fernando Fernandez-Llimos,Roberto Pontarolo
European Journal of Cancer.2018;104()9
[DOI]
2Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades
Mohd. Imran,Syed Mohammed Basheeruddin Asdaq,Shah Alam Khan,Dhanalekshmi Unnikrishnan Meenakshi,Abdulhakeem S. Alamri,Walaa F. Alsanie,Majid Alhomrani,Yahya Mohzari,Ahmed Alrashed,Mohammed AlMotairi,Eman H. Alkhaldi,Abeer K. Alorabi,Ahmed Subeh Alshrari,Mohammad Tauseef,Mohammad Abida,Saleh I. Alaqel,Ozair Alam,Md. Afroz Bakht
Pharmaceuticals.2021;14(8)710
[DOI]
3Amyloid -induced elevation of O-GlcNAcylated c-Fos promotes neuronal cell death
Heesun Choi,Chaeyoung Kim,Hyundong Song,Moon-Yong Cha,Hyun Jin Cho,Sung Min Son,Haeng Jun Kim,Inhee Mook-Jung
Aging Cell.2019;18(1)e12872
[DOI]
  Site Map | What's new | Copyright and Disclaimer | Privacy Notice
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow